ClinicalTrials.Veeva

Menu

Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery (SFMCA)

B

Beni-Suef University

Status

Unknown

Conditions

Preterm Delivery

Treatments

Procedure: serum ferritin
Procedure: MCA Doppler

Study type

Observational

Funder types

Other

Identifiers

NCT02420743
Beni-Suef 10

Details and patient eligibility

About

Pregnant women with iron deficiency anemia during third trimester will be assessed for serum ferritin and peak systolic value for fetal middle cerebral artery to find out their correlation with preterm delivery.

Full description

Preterm delivery, defined as delivery before 37 weeks of completed gestation (259 days), is a major cause of neonatal morbidity and mortality. Despite extensive research, preterm birth still accounts for 5-10% of all deliveries in developed countries and rates are on the increase, including in the UK. While mortality associated with preterm delivery has declined due to use of antenatal steroids and improvements in neonatal intensive care, preterm babies still remain at risk of major complications. These include respiratory distress syndrome, necrotising enterocolitis, retinopathy of prematurity, sepsis, intraventricular haemorrhage, periventricular leucomalacia and long-term cognitive and sensory impairment. Two major determinants for the mortality and morbidity of babies born preterm are gestation at delivery and birthweight. Prematurity therefore carries significant cost implications to both healthcare services and society in general. High hemoglobin along with anemia was examined in an observational study. At entry to care, which ranged between 6 and 8.4 wk gestation, women with hemoglobin levels exceeding 130g/L had a greater than twofold increase in risk of preterm delivery and infant low birth weight. Neither risk was statistically significant, however, because of the small numbers with high hemoglobin. Similarly, a concentration of the iron storage protein, ferritin, that is high for the third trimester of pregnancy is also associated with an increased risk for preterm and very preterm delivery. Over the last twenty years, interest has been shown in using ultrasound parameters or Doppler studies of fetal blood to assess fetal anaemia. Middle cerebral artery Doppler has taken over and has replaced amniocentesis as a screening test for fetal anaemia in high risk pregnancies.

Enrollment

100 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant female from 24 weeks till 37 weeks gestation.
  • Patients diagnosed as iron deficiency anemia.

Exclusion criteria

  • Medical disorders as hypertension or diabetes.
  • Kidney and liver diseases.
  • Any other causes of anemia as haemoglobinopathies.

Trial contacts and locations

1

Loading...

Central trial contact

Abdelgany M Hassan, MD; Nesreen A Shehata, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems